|
EP1039902B1
(en)
*
|
1997-11-24 |
2006-03-08 |
The Scripps Research Institute |
Inhibitors of gap junction communication
|
|
US6858649B1
(en)
*
|
1998-04-30 |
2005-02-22 |
The Scripps Research Institute |
Selective potentiation of serotonin receptor subtypes
|
|
GB9926833D0
(en)
*
|
1999-11-15 |
2000-01-12 |
Univ Sunderland |
Compositions
|
|
AU2002243920A1
(en)
*
|
2001-02-08 |
2002-08-19 |
Nps Pharmaceuticals, Inc. |
Methods and compounds for treating neurologic or neuropsychiatric disorders and identifying compounds to treat the same
|
|
US20050054730A1
(en)
*
|
2001-03-27 |
2005-03-10 |
The Regents Of The University Of California |
Compounds, compositions and treatment of oleoylethanolamide-like modulators of PPARalpha
|
|
WO2002080860A2
(en)
|
2001-03-27 |
2002-10-17 |
The Regents Of The University Of California |
Methods, compounds, and compositions for reducing body fat and modulating fatty acid metabolism
|
|
EP1419237A4
(en)
*
|
2001-07-31 |
2005-12-21 |
Scripps Research Inst |
ANIMAL MODEL FOR NEURO BEHAVIOR IN CONNECTION WITH FATTY ACID AMIDES
|
|
ES2186576B1
(es)
*
|
2001-10-11 |
2004-09-16 |
Universitat De Les Illes Balears |
Acido 2-hidroxioleico para utilizar como medicamento.
|
|
US20040063726A1
(en)
*
|
2002-02-08 |
2004-04-01 |
Artman Linda D |
Methods and compounds for treating neurologic or neuropsychiatric disorders and identifying compounds to treat the same
|
|
US7765162B2
(en)
*
|
2002-10-07 |
2010-07-27 |
Mastercard International Incorporated |
Method and system for conducting off-line and on-line pre-authorized payment transactions
|
|
WO2004033422A2
(en)
*
|
2002-10-07 |
2004-04-22 |
The Regents Of The University Of California |
Modulation of anxiety through blockade of anandamide hydrolysis
|
|
WO2005046580A2
(en)
*
|
2003-10-16 |
2005-05-26 |
The Regents Of The University Of California |
Dietary and other compositions, compounds, and methods for reducing body fat, controlling appetite, and modulating fatty acid metabolism
|
|
EP2937341B1
(en)
|
2004-12-30 |
2017-07-05 |
Janssen Pharmaceutica N.V. |
4-(benzyl)-piperazine-1-carboxylic acid phenylamide derivatives and related compounds as modulators of fatty acid amide hydrolase (faah) for the treatment of anxiety, pain and other conditions
|
|
WO2006116773A2
(en)
*
|
2005-04-28 |
2006-11-02 |
The Regents Of The University Of California |
Methods, compositions, and compounds for modulation of monoacylglycerol lipase, pain, and stress-related disorders
|
|
WO2007005510A1
(en)
|
2005-06-30 |
2007-01-11 |
Janssen Pharmaceutica N.V. |
N-heteroarylpiperazinyl ureas as modulators of fatty acid amide hydrolase
|
|
WO2007061862A2
(en)
|
2005-11-18 |
2007-05-31 |
Janssen Pharmaceutica N.V. |
2-keto-oxazoles as modulators of fatty acid amide hydrolase
|
|
WO2007098142A2
(en)
|
2006-02-17 |
2007-08-30 |
The Scripps Research Institute |
Oxazole ketones as modulators of fatty acid amide hydrolase
|
|
JP2009538358A
(ja)
*
|
2006-05-26 |
2009-11-05 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
脂肪酸アミド加水分解酵素のオキサゾリルピペリジン・モジュレーター
|
|
US20080089845A1
(en)
*
|
2006-09-07 |
2008-04-17 |
N.V. Organon |
Methods for determining effective doses of fatty acid amide hydrolase inhibitors in vivo
|
|
JO3598B1
(ar)
|
2006-10-10 |
2020-07-05 |
Infinity Discovery Inc |
الاحماض والاسترات البورونية كمثبطات اميد هيدروليز الحامض الدهني
|
|
EP2096915A1
(en)
*
|
2006-11-20 |
2009-09-09 |
N.V. Organon |
Metabolically-stabilized inhibitors of fatty acid amide hydrolase
|
|
WO2009126691A1
(en)
*
|
2008-04-09 |
2009-10-15 |
Infinity Pharmaceuticals, Inc |
Inhibitors of fatty acid amide hydrolase
|
|
ES2342997B1
(es)
|
2008-12-09 |
2011-06-06 |
Universitat De Les Illes Balears |
Alpha derivados de acidos grasos cis-monoinsaturados para ser usados como medicamento.
|
|
WO2010118155A1
(en)
|
2009-04-07 |
2010-10-14 |
Infinity Pharmaceuticals, Inc. |
Inhibitors of fatty acid amide hydrolase
|
|
EP2417115A4
(en)
|
2009-04-07 |
2012-10-31 |
Infinity Pharmaceuticals Inc |
FATTY ACID AMIDE HYDROLASE INHIBITORS
|
|
US9062116B2
(en)
|
2009-04-23 |
2015-06-23 |
Infinity Pharmaceuticals, Inc. |
Anti-fatty acid amide hydrolase-2 antibodies and uses thereof
|
|
US9149465B2
(en)
*
|
2009-05-18 |
2015-10-06 |
Infinity Pharmaceuticals, Inc. |
Isoxazolines as inhibitors of fatty acid amide hydrolase
|
|
US8927551B2
(en)
*
|
2009-05-18 |
2015-01-06 |
Infinity Pharmaceuticals, Inc. |
Isoxazolines as inhibitors of fatty acid amide hydrolase
|
|
US8765735B2
(en)
*
|
2009-05-18 |
2014-07-01 |
Infinity Pharmaceuticals, Inc. |
Isoxazolines as inhibitors of fatty acid amide hydrolase
|
|
WO2011060026A1
(en)
|
2009-11-12 |
2011-05-19 |
Jansen Pharmaceutica Nv |
Piperazinecarboxamide derivative useful as a modulator of fatty acid amide hydrolase (faah)
|
|
MX336742B
(es)
*
|
2010-02-03 |
2016-01-29 |
Infinity Pharmaceuticals Inc |
Inhibidores de amida hidrolasa de acido graso.
|
|
UA108233C2
(uk)
|
2010-05-03 |
2015-04-10 |
|
Модулятори активності гідролази амідів жирних кислот
|
|
US11078528B2
(en)
|
2015-10-12 |
2021-08-03 |
Advanced Cell Diagnostics, Inc. |
In situ detection of nucleotide variants in high noise samples, and compositions and methods related thereto
|
|
US12378178B2
(en)
|
2019-11-12 |
2025-08-05 |
The Trustees Of The University Of Pennsylvania |
Oleic acid derivatives as treatments for Friedreich ataxia and inhibitors of ferroptosis
|
|
CN111004125B
(zh)
*
|
2019-12-24 |
2022-11-22 |
东华理工大学 |
一种缩醛或缩酮化合物的制备方法
|
|
CN115052852A
(zh)
|
2020-01-29 |
2022-09-13 |
巴利阿里群岛大学 |
α-羟基化脂肪酸代谢产物、其医学用途以及作为生物标志物的用途
|